| Accession | SAMC1783936 |
|---|---|
| Accession in Other Database | GSA-Human: HRS193004 |
| Sample name | CR_P3_N2 |
| Title | CR_P3_N2 |
| Sample type | Human sample |
| Organism | Homo sapiens |
| Description | Normal |
| Attributes | *This sample record contains additional controlled-access information that is avaiable from GSA-Human by requesting study HRA000936 in the GSA-Human system. |
| Release date | 2021-06-16 |
| BioProject Accession | PRJCA005479 |
| Submitter | Qimin Zhan (zhanqimin@bjmu.edu.cn) |
| Organization | Peking University Cancer Hospital & Institute |
| Submission date | 2023-06-18 |
| Resource name | Description |
|---|---|
| GSA-Human (1) | - |
| HRA000936 (Controlled Access) | Targeted arterial infusion of verapamil combined with chemotherapy (TVCC) is an effective clinical interventional therapy for esophageal squamous cell carcinoma (ESCC), but multidrug resistance (MDR) remains the major cause of relapse or poor prognosis, and the underlying molecular mechanisms of MDR, temporal intratumoral heterogeneity and clonal evolutionary processes of resistance have not been determined. |